However, up to 10% of full-length SMN is produced by the centromeric homologous SMN2 gene, which partially compensates the lack of SMN1. Hence, SMN2 copy number has been found inversely correlated with disease severity, contributing decisively to the observed SMA clinical heterogeneity [2]. Here, SMN1 is linked to proximal spinal muscular atrophy.